139 related articles for article (PubMed ID: 38216167)
1. Sweet syndrome following the ChAdOx1-S vaccine.
Baker O; Chen KS; Kaminska I; Rajagopal V
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38216167
[TBL] [Abstract][Full Text] [Related]
2. Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female.
Majid I; Mearaj S
Dermatol Ther; 2021 Nov; 34(6):e15146. PubMed ID: 34590397
[TBL] [Abstract][Full Text] [Related]
3. Sweet syndrome presenting as a febrile rash in a returning traveller.
Hart A; Plenk K; Carr D
CJEM; 2018 May; 20(3):476-478. PubMed ID: 28534449
[TBL] [Abstract][Full Text] [Related]
4. Bullous Sweet syndrome following SARS-CoV-2 Oxford AstraZeneca vaccine.
Žagar T; Hlača N; Brajac I; Prpić-Massari L; Peternel S; Kaštelan M
Br J Dermatol; 2022 Mar; 186(3):e110. PubMed ID: 34817862
[No Abstract] [Full Text] [Related]
5. Pemetrexed-induced Sweet Syndrome: First case report in the medical literature.
Korkmaz M; Eryılmaz MK; Karaağaç M; Demirkıran A; Araz M; Artaç M
J Oncol Pharm Pract; 2021 Jul; 27(5):1307-1310. PubMed ID: 33028131
[TBL] [Abstract][Full Text] [Related]
6. Acute encephalitis, myoclonus and Sweet syndrome after mRNA-1273 vaccine.
Torrealba-Acosta G; Martin JC; Huttenbach Y; Garcia CR; Sohail MR; Agarwal SK; Wasko C; Bershad EM; Hirzallah MI
BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34312136
[TBL] [Abstract][Full Text] [Related]
7. Photo-Induced Sweet Syndrome: A Case Report.
Badshah M; Nadeem I; Foerster CE; Tjarks BJ; Shriver J; Ahmed M
S D Med; 2023 Feb; 76(2):56-59. PubMed ID: 36898069
[TBL] [Abstract][Full Text] [Related]
8. Neutrophilic Dermatosis Limited to Lipo-Lymphedematous Skin in a Morbidly Obese Woman on Dasatinib Therapy.
Ainechi S; Carlson JA
Am J Dermatopathol; 2016 Feb; 38(2):e22-6. PubMed ID: 26825166
[TBL] [Abstract][Full Text] [Related]
9. Chest pain, fever and vesicular rash presenting as symptoms of Sweet syndrome.
Lefrançois F; Avenel-Audran M; Rouleau F; Croué A; Verret JL; Martin L
Eur J Dermatol; 2012; 22(5):682-3. PubMed ID: 23017830
[No Abstract] [Full Text] [Related]
10. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Ramasamy MN; Minassian AM; Ewer KJ; Flaxman AL; Folegatti PM; Owens DR; Voysey M; Aley PK; Angus B; Babbage G; Belij-Rammerstorfer S; Berry L; Bibi S; Bittaye M; Cathie K; Chappell H; Charlton S; Cicconi P; Clutterbuck EA; Colin-Jones R; Dold C; Emary KRW; Fedosyuk S; Fuskova M; Gbesemete D; Green C; Hallis B; Hou MM; Jenkin D; Joe CCD; Kelly EJ; Kerridge S; Lawrie AM; Lelliott A; Lwin MN; Makinson R; Marchevsky NG; Mujadidi Y; Munro APS; Pacurar M; Plested E; Rand J; Rawlinson T; Rhead S; Robinson H; Ritchie AJ; Ross-Russell AL; Saich S; Singh N; Smith CC; Snape MD; Song R; Tarrant R; Themistocleous Y; Thomas KM; Villafana TL; Warren SC; Watson MEE; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Faust SN; Pollard AJ;
Lancet; 2021 Dec; 396(10267):1979-1993. PubMed ID: 33220855
[TBL] [Abstract][Full Text] [Related]
11. Sweet syndrome: a painful reality.
Khan U; Rizvi H; Ali F; Lebovic D
BMJ Case Rep; 2016 Dec; 2016():. PubMed ID: 28011887
[TBL] [Abstract][Full Text] [Related]
12. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
Voysey M; Costa Clemens SA; Madhi SA; Weckx LY; Folegatti PM; Aley PK; Angus B; Baillie VL; Barnabas SL; Bhorat QE; Bibi S; Briner C; Cicconi P; Clutterbuck EA; Collins AM; Cutland CL; Darton TC; Dheda K; Dold C; Duncan CJA; Emary KRW; Ewer KJ; Flaxman A; Fairlie L; Faust SN; Feng S; Ferreira DM; Finn A; Galiza E; Goodman AL; Green CM; Green CA; Greenland M; Hill C; Hill HC; Hirsch I; Izu A; Jenkin D; Joe CCD; Kerridge S; Koen A; Kwatra G; Lazarus R; Libri V; Lillie PJ; Marchevsky NG; Marshall RP; Mendes AVA; Milan EP; Minassian AM; McGregor A; Mujadidi YF; Nana A; Padayachee SD; Phillips DJ; Pittella A; Plested E; Pollock KM; Ramasamy MN; Ritchie AJ; Robinson H; Schwarzbold AV; Smith A; Song R; Snape MD; Sprinz E; Sutherland RK; Thomson EC; Török ME; Toshner M; Turner DPJ; Vekemans J; Villafana TL; White T; Williams CJ; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Pollard AJ;
Lancet; 2021 Mar; 397(10277):881-891. PubMed ID: 33617777
[TBL] [Abstract][Full Text] [Related]
13. Acute febrile neutrophilic dermatosis (Sweet's syndrome) in a patient with biliary sepsis.
Yong AS; Lee KY; Murphy J; Phillips M; Rushbrook S; Garioch JJ
Postgrad Med J; 2013 Dec; 89(1058):731-2. PubMed ID: 24048149
[No Abstract] [Full Text] [Related]
14. Panuveitis in Sweet syndrome.
Ngan K; Leong JCY; Long H
Indian J Ophthalmol; 2020 Sep; 68(9):2004-2006. PubMed ID: 32823459
[TBL] [Abstract][Full Text] [Related]
15. Neutrophilic urticarial dermatosis as a presenting feature of systemic juvenile idiopathic arthritis.
Stringer T; Gittler J; Meehan S; Kahn P; Oza VS
Pediatr Dermatol; 2018 May; 35(3):e170-e172. PubMed ID: 29574969
[TBL] [Abstract][Full Text] [Related]
16. The importance of skin biopsies: Sweet syndrome as a differential for 'acute painful red rash' in a patient with normal neutrophils and polymyalgia rheumatica on glucocorticoids.
Rajakulenthiran TG; Amarasena R; Singh R; Kelly S; Silva S
Clin Med (Lond); 2020 Mar; 20(Suppl 2):s25. PubMed ID: 32409350
[No Abstract] [Full Text] [Related]
17. Lymphedema-associated neutrophilic dermatosis: Two cases of localized Sweet syndrome on the lymphedematous lower limbs.
Chu CH; Cheng YP; Kao HL; Liang CW; Chan JY; Yu Y
J Dermatol; 2016 Sep; 43(9):1062-6. PubMed ID: 27099208
[TBL] [Abstract][Full Text] [Related]
18. An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females.
Marchevsky NG; Li G; Aley P; Costa Clemens SA; Barrett JR; Belij-Rammerstorfer S; Bibi S; Clutterbuck E; Dold C; Felle S; Flaxman A; Folegatti P; Jenkin D; Gilbert S; Kelly S; Lambe T; Plested E; Ramasamy M; Singh N; Smith H; Taylor S; Weckx L; Pollard AJ; Voysey M;
EBioMedicine; 2022 Jul; 81():104128. PubMed ID: 35779491
[TBL] [Abstract][Full Text] [Related]
19. Azathioprine hypersensitivity: A Sweet-like syndrome.
Sivanandam LK; Begum B; Martinez EC; Garikipati S; Sanker V; Siddiq A
Int J Rheum Dis; 2024 Jan; 27(1):e14817. PubMed ID: 37401805
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
Li G; Cappuccini F; Marchevsky NG; Aley PK; Aley R; Anslow R; Bibi S; Cathie K; Clutterbuck E; Faust SN; Feng S; Heath PT; Kerridge S; Lelliott A; Mujadidi Y; Ng KF; Rhead S; Roberts H; Robinson H; Roderick MR; Singh N; Smith D; Snape MD; Song R; Tang K; Yao A; Liu X; Lambe T; Pollard AJ;
Lancet; 2022 Jun; 399(10342):2212-2225. PubMed ID: 35691324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
